It delineates the compositional and functional attributes of the gut, urinary, and prostatic microbiota associated with tumor initiation, progression, and therapeutic response, while elucidating the molecular and immunometabolic pathways through which microbial metabolites, inflammatory signaling, and androgen receptor (AR) modulation converge to shape disease biology. This evidence concerns the gene AR and neoplasm.